Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Penelope MacRae

Set Alert for Articles By Penelope MacRae

Latest From Penelope MacRae

Indian Insurer Urges Hospitals To Prescribe Generics As ‘No Name’ Campaign Gathers Pace

A major Indian health insurance provider is pushing hospitals to prescribe no-name generic medicines – a move that if adopted industry-wide could potentially lower patient bills, reduce insurance payouts, cut premium rates and help address glaring challenges around healthcare financing in the country.

India Policy

Dr. Reddy’s Warns US Market ‘Unpredictable’ As Q4 Profit Below Expectations

Dr. Reddy’s Laboratories, India’s second-largest drug firm by sales, has warned that its key US export market remains “unpredictable” after reporting a lower than expected fourth-quarter net profit that capped a tough year.

India Commercial

India Premier Pushes For Generic Prescriptions But Hurdles Loom

India’s prime minister has declared that doctors should prescribe medicines using only non-proprietary generic names in an effort to reduce medical bills, but the medical fraternity says the move could jeopardize patient safety, while hurdles mean others see only limited pharma industry impact in the short term.

India Policy

Biocon Cautiously Optimistic On Earnings Prospects Amid Slower Approvals

India’s biggest biotech firm has said it is “cautiously optimistic” about its performance this financial year after fourth-quarter net profit slid due to an exceptional item in the previous year, but reports progress on multiple fronts for its large biosimilar portfolio.

India Commercial

Singh Bros Agree Religare Sale As Daiichi Settlement Case Roils

Religare Enterprises, led by Indian tycoons Malvinder and Shivinder Singh who are locked in a bitter arbitration battle with Daiichi Sankyo, has sold off its health insurance unit as it seeks to pare debt and focus on core financial services, in a move the brothers’ lawyers say is designed to raise capital.

India Commercial

Hilleman’s Pioneering Shigella Vaccine Set For First Trials

India’s Hilleman Laboratories, in partnership with a government agency, expects to start human trials this year with a pioneering multivalent vaccine to prevent shigellosis, a highly contagious bacterial diarrheal disease that is a major killer of children in low-income countries but has proven a difficult vaccine target.

Vaccines Infectious Diseases
See All